Log in to your flu360® account to view your notifications, financial dashboard, and manage your orders today.
FLUCELVAX® is the first and only FDA-approved cell-based seasonal influenza vaccine in the US. Visit flu360.com to learn more.
AFLURIA® is a seasonal flu vaccine approved for ages 6 months and older and is for a wide range of patients. Learn more at flu360.com.
AFLURIA® is a seasonal flu vaccine approved for ages 6 months and older and is for a wide range of patients. Learn more at flu360.com.
We are CSL Seqirus. One of the world's largest influenza vaccine manufacturers and the only company fully dedicated to flu prevention. With over a century's worth of innovations, CSL Seqirus provides the experience needed to help fight flu with flu360.
flu360 offers clinical, financial, and operational solutions for your flu vaccination business year-round. Learn more and partner with CSL Seqirus at flu360.com.
flu360 offers clinical, financial, and operational solutions for your flu vaccination business year-round. Learn more and partner with CSL Seqirus at flu360.com.
Seqirus released new data that shows Fluad, an adjuvanted trivalent influenza vaccine, was more effective than standard non-adjuvanted trivalent influenza vaccine in reducing the risk of flu- and pneumonia-related hospitalization in patients 65-years-of-
FLUAD® with MF59® Adjuvant is a flu vaccine designed to strengthen, broaden, and lengthen the duration of the immune response and is approved for patients 65+. Visit flu360.com to learn more.
Seqirus, for its part, said the group will utilize artificial intelligence to continually improve flu vaccine R&D. A universal flu shot has been called a "holy grail" in vaccine development, and recent efficacy problems with traditional flu shots have brought new attention to the field. Numerous...